- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01759368
Heart at Home- a Self-care Study
15. september 2014 opdateret af: VTT Technical Research Centre of Finland
Heart at Home- Remote Patient Monitoring in the Care of Heart Failure Patients
In the study benefits of using mobile phone assisted remote patient monitoring including self-measurements of blood pressure, heart rate and weight as well as monitoring of personal health status are investigated in the care of heart failure patients.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
94
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Espoo, Finland
- VTT Technical Research Centre of Finland
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 90 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- diagnosis of systolic heart failure
- NYHA (New York Heart Association) classification > 1
- left ventricular ejection fraction ≤ 35%
- need for a regular control visit
- time from the last visit no longer than 6 months
Exclusion Criteria:
- Patients who were known to enter a major medical operation
- severe comorbidity,
- participation in other clinical trial during last three months-
- poor compliance in terms of familiarity with mobile phone
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Telemonitoring assisted self-care
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
|
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring
|
|
Ingen indgriben: Control group
Control group received usual care that includes multidisciplinary care approach in which patients receive guidance and support for self-care.
In the care of heart failure (HF) patients, the cardiac team plays a central role in monitoring and interpreting patient symptoms, optimizing medication and providing education.
The cardiac team consists of two physicians, one specialized heart failure nurse and a physiotherapist who helps after a hospitalization period.
As part of the care process, patients capable of carrying out self-care are identified and they are encouraged to regularly measure their blood pressure, heart rate and weight at home.
So far, the information exchange between heart failure patients and care personnel has taken place during patients' visits to the clinic and by telephone.
Systematic collection and exploitation of the self-measurement data has been difficult, since it depends on the patient's own activity
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of HF-related Hospital Days
Tidsramme: From baseline until the end of the study at six months
|
Number of heart failure related hospital days
|
From baseline until the end of the study at six months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Death
Tidsramme: From baseline until the end of the study at six months
|
Death from any cause
|
From baseline until the end of the study at six months
|
|
Heart Transplant
Tidsramme: From baseline until the end of the study at six months
|
Heart transplant operation or listing for transplant operation
|
From baseline until the end of the study at six months
|
|
P-proBNP
Tidsramme: From baseline until the end of the study at six months
|
Change in plasma concentration of brain natriuretic peptide propeptide from baseline to the end of the study.
|
From baseline until the end of the study at six months
|
|
EHFSBS (European Heart Failure Self-Care Behaviour Scale ) Scores
Tidsramme: From baseline until the end of the study at six months
|
Change in self-care behaviour measured by the European Heart Failure Self-Care Behaviour Scale (EHFSBS).
EHFSBS is a 12-item self-administered questionnaire specifically designed and tested for heart failure patients including statements on self-care behaviour essential in the care of HF.
The statements are scored from one to five.
The lower the score, the better the performance in self-care.
The summary score is analysed.
|
From baseline until the end of the study at six months
|
|
Left Ventricular Ejection Fraction
Tidsramme: From baseline until the end of the study at six months
|
Change in left ventricular ejection fraction from baseline until the end of the study
|
From baseline until the end of the study at six months
|
|
Utilization of Health Care Resources
Tidsramme: From baseline until the end of the study at six months
|
Number of visits to nurse's reception
|
From baseline until the end of the study at six months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Plasma Concentrations of Creatinine, Natrium, and Potassium From the Baseline to the End of the Study
Tidsramme: From baseline to the end of the study at six months
|
Change in plasma concentrations of creatinine, natrium, and potassium
|
From baseline to the end of the study at six months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. oktober 2010
Primær færdiggørelse (Faktiske)
1. marts 2012
Studieafslutning (Faktiske)
1. juni 2012
Datoer for studieregistrering
Først indsendt
20. december 2012
Først indsendt, der opfyldte QC-kriterier
30. december 2012
Først opslået (Skøn)
3. januar 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
17. september 2014
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
15. september 2014
Sidst verificeret
1. september 2014
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- HUSHAH
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjertefejl
-
Fondation Hôpital Saint-JosephRekruttering
-
Region SkaneTilmelding efter invitationHjertesvigt New York Heart Association (NYHA) klasse II | Hjertesvigt New York Heart Association (NYHA) klasse IIISverige
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus... og andre samarbejdspartnereAfsluttetHjertesvigt, systolisk | Hjertesvigt med reduceret udstødningsfraktion | Hjertesvigt New York Heart Association Klasse IV | Hjertesvigt New York Heart Association Klasse IIIPolen
-
Portuguese Association of Interventional CardiologyMedtronicRekrutteringSvær Symptomatisk Aortastenose (Defineret som New York Heart Association (NYHA) klasse ≥ II)Portugal
-
University of WashingtonAmerican Heart AssociationAfsluttetHjertesvigt, Kongestiv | Mitokondriel ændring | Hjertesvigt New York Heart Association Klasse IVForenede Stater
-
Novartis PharmaceuticalsAfsluttetPatienter, der med succes afslutter den 12-måneders behandlingsperiode i kernestudiet (de Novo Heart-modtagere), som var interesserede i at blive behandlet med EC-MPS
-
University Hospital, GasthuisbergUkendtTransient Left Ventricular Ballooning SyndromeBelgien
-
NYU Langone HealthRekrutteringTako-tsubo kardiomyopati | Takotsubo kardiomyopati | Broken Heart SyndromeForenede Stater
-
French Cardiology SocietyAfsluttet